Vasogen(加拿大)

Vasogen

加拿大VasogenIncwww.vasogen.comVasogenInc.(多伦多，Toronto)是以心血管疾病或神经疾病所引发的慢性发炎作为治疗标靶，来进行新药物科技研发的公司，宣布ChristopherJ.Waddick被擢升为营运长，PaulJ.VanDamme担任财务部门副总裁及财务长，JacquelineH.R.LeSaux担任公司及法律业务部门副总裁Weareabiotechno logycompanythatisfocusedontheresearchandcommercialdevelopmentoftherapiesdesignedtotargetthedestructiveinflammatoryprocessesassociatedwiththedevelopmentandprogressionofcardiovascularandneuro-inflammatorydisorders.Ourmostadvancedproduct,theCelacade™System,isdesignedtoactivatetheimmuneresponsetoapoptosis–animportantphysiologicalprocessthatregulatesinflammation.Wearealsodevelopinganewclassofdrugsforthetreatmentofcertainneuro-inflammatorydisorders.Ourtwoinitialproductcandidates,VP015andVP025,arebiologicalligandsdesignedtoexploitspecificphysiologicalanti-inflammatoryresponsesoftheimmunesystem.Theeffectsofthesedrugshavebeenshowntocrosstheblood-brai